Veterinary Medicines

Thyroxanil 200 microgram tablets for dogs and cats

Authorised
  • Anhydrous levothyroxine sodium
Download as PDF

Product identification

Medicine name:
Thyroxanil 200 microgram tablets for dogs and cats
Thyroxanil vet, 200 mikrogrammi tabletid koertele ja kassidele
Active substance:
  • Anhydrous levothyroxine sodium
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Anhydrous levothyroxine sodium
    0.20
    milligram(s)
    /
    1.00
    Piece
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • Cardboard box of 2 Aluminium - PVC blisters with 25 tablets per blister.
  • Cardboard box of 10 Aluminium - PVC blisters with 30 tablets per blister.
  • Cardboard box of 4 Aluminium - PVC blisters with 30 tablets per blister.
  • Cardboard box of 4 Aluminium - PVC blisters with 25 tablets per blister.
  • Cardboard box of 1 Aluminium - PVC blister with 30 tablets per blister.
  • Cardboard box of 1 Aluminium - PVC blister with 25 tablets per blister.
  • Cardboard box of 7 Aluminium - PVC blisters with 30 tablets per blister.
  • Cardboard box of 7 Aluminium - PVC blisters with 25 tablets per blister.
  • Cardboard box of 6 Aluminium - PVC blisters with 30 tablets per blister.
  • Cardboard box of 6 Aluminium - PVC blisters with 25 tablets per blister.
  • Cardboard box of 5 Aluminium - PVC blisters with 25 tablets per blister.
  • Cardboard box of 3 Aluminium - PVC blisters with 25 tablets per blister.
  • Cardboard box of 2 Aluminium - PVC blisters with 30 tablets per blister.
  • Cardboard box of 10 Aluminium - PVC blisters with 25 tablets per blister.
  • Cardboard box of 9 Aluminium - PVC blisters with 30 tablets per blister.
  • Cardboard box of 9 Aluminium - PVC blisters with 25 tablets per blister.
  • Cardboard box of 8 Aluminium - PVC blisters with 30 tablets per blister.
  • Cardboard box of 8 Aluminium - PVC blisters with 25 tablets per blister.
  • Cardboard box of 5 Aluminium - PVC blisters with 30 tablets per blister.
  • Cardboard box of 3 Aluminium - PVC blisters with 30 tablets per blister.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
  • Lindopharm GmbH
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1965
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0195/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 10/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."